Guardion Health Sciences Inc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 0.23
Dividend & YieldN/A$ (N/A)
Beta 0.85
Market capitalization 10.47M
Operating cash flow -7.65M
ESG Scores unknown

Company description

Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It also provides MapcatSF, a medical device that measures the macular pigment optical density; CSV-1000 device that offers auto-calibrated tests to ensure the correct testing luminance and contrast levels; and CSV-2000, a digital standardized contrast sensitivity testing device, as well as develops, manufactures, and sells equipment and supplies for standardized vision testing under the VectorVision name for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing. In addition, the company develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.

Sector: Healthcare - Industry: Drug Manufacturers—Specialty & Generic

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 102.69k -14.24k 479.18k -680.7k
Total Cashflows From Investing Activities -310.24k -171.08k -34.73k -31.01M
Net Borrowings -176.67k 249.45k
Total Cash From Financing Activities 419.79k 16.65M 5.45M 37.23M
Change To Operating Activities 137.48k -415.2k -116.35k -585.99k
Issuance Of Stock 866.46k 16.4M 5.45M 37.23M
Net Income -7.77M -10.88M -8.57M -24.75M
Change In Cash -4.06M 10.44M -2.6M -4.42M
Effect Of Exchange Rate
Total Cash From Operating Activities -4.17M -6.03M -8.01M -10.64M
Depreciation 295.67k 625.79k 219.6k 907.55k
Change To Account Receivables 44.57k -50.13k 67.09k 378.68k
Other Cashflows From Financing Activities -270k
Change To Netincome 3.22M 4.41M 637.01k 13.63M
Capital Expenditures -260.24k -171.08k -40.73k -74.59k

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 231.85k 194.31k 160.98k 64.36k
Income Before Tax -7.77M -10.88M -8.57M -24.75M
Net Income -7.77M -10.88M -8.57M -24.75M
Selling General Administrative 6.46M 9.3M 8.9M 13.53M
Gross Profit 543.97k 561.62k -56.79k 3.11M
Ebit -6.14M -8.93M -9.12M -10.48M
Operating Income -6.14M -8.93M -9.12M -10.48M
Interest Expense -2.29k -258.37k -7.27k
Income Tax Expense
Total Revenue 942.15k 902.94k 1.89M 7.23M
Cost Of Revenue 398.18k 341.31k 1.95M 4.12M
Total Other Income ExpenseNet -1.62M -1.94M 546.56k -14.26M
Net Income From Continuing Ops -7.77M -10.88M -8.57M -24.75M
Net Income Applicable To Common Shares -7.77M -10.88M -8.57M -24.75M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 495.34k 844.98k 1.35M 1.16M
Total Stockholder Equity 3.19M 12.03M 8.52M 22.3M
Other Current Liabilities 13.32k 25.98k
Total Assets 3.68M 12.88M 9.86M 23.46M
Common Stock 20.56k 12.5k 15.17k 24.43k
Other Current Assets
Retained Earnings -34.63M -45.51M -54.08M -78.8M
Treasury Stock
Cash 670.95k 11.12M 8.52M 4.09M
Total Current Liabilities 495.34k 410.23k 1.07M 1.16M
Other Stockholder Equity
Property, Plant, and Equipment 274.8k 947.35k 704.27k 135.63k
Total Current Assets 1.1M 11.87M 9.09M 12.07M
Net Tangible Assets 1.17M 11.98M 8.47M 11.04M
Net Receivables 28.2k 78.34k 11.25k 1.83M
Accounts Payable 413.93k 129.13k 608.31k 241.35k


Insider Transactions

Here are the insider transactions of stock shares related to Guardion Health Sciences Inc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
SCHOLTES BRET DPurchase at price 1.23 - 1.26 per share.D2021-08-31Chief Executive Officer10k
GAGLIANO DONALD APurchase at price 1.25 per share.D2021-08-30Director5k
WEINGARTEN ROBERT NEALStock Award(Grant) at price 1.14 per share.D2021-08-20Director10k
SCHOLTES BRET DStock Award(Grant) at price 0.00 per share.D2021-01-06Chief Executive Officer916.02k
SCHOLTES BRET DStock Award(Grant) at price 0.00 per share.D2021-01-06Chief Executive Officer152.67k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Guardion Health Sciences Inc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Guardion Health Sciences Inc

Here is the result of two systematic investment strategies applied to Guardion Health Sciences Inc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Guardion Health Sciences Inc

The following chart shows the equity curve of the two systematic investment strategies applied to Guardion Health Sciences Inc:

Guardion Health Sciences Inc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -23.1% on the backtest period.

Performance at glance

Performance

-23.1 %

Latent gain

-288.04 $

Invested capital

1246.97 $

Annualized return

-8.56 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Guardion Health Sciences Inc

This is the result of two momentum investment strategies applied to Guardion Health Sciences Inc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Guardion Health Sciences Inc

The following chart shows all the entries opened by the momentum investment system on Guardion Health Sciences Inc:

Guardion Health Sciences Inc momentum entries
  • The first momentum investment strategy would give -19.71% of return on Guardion Health Sciences Inc. That represents -592.1$ of latent gain with 3004.72$ of employed capital.
  • The second momentum investment strategy would give -8.55% of return on Guardion Health Sciences Inc. That represents -171.35$ of latent gain with 2004.09$ of employed capital.
Performance at glance (1Q Momentum)

Performance

-19.71 %

Latent gain

-592.1 $

Invested capital

3004.72 $

Annualized return

0.0 %
Performance at glance (2Q Momentum)

Performance

-8.55 %

Latent gain

-171.35 $

Invested capital

2004.09 $

Annualized return

-3.85 %

Momentum equity curve on Guardion Health Sciences Inc

The following chart shows the equity curve of the two momentum strategies applied to Guardion Health Sciences Inc:

Guardion Health Sciences Inc momentum equity

Note: the dividends potentially given by Guardion Health Sciences Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Guardion Health Sciences Inc

The following chart shows the employed capital evolution of the two momentum strategies on Guardion Health Sciences Inc since the beginning:

Guardion Health Sciences Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Guardion Health Sciences Inc

Buy the dip entry openings on Guardion Health Sciences Inc

Guardion Health Sciences Inc

The performance achieved by the robo-advisor on Guardion Health Sciences Inc is 0%. That represents 0.0$ of latent gain with 0.0$ of employed capital. The following chart shows Guardion Health Sciences Inc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Guardion Health Sciences Inc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 $

Invested capital

0.0 $

Annualized return

0.0 %

Equity curve of the strategy applied to Guardion Health Sciences Inc

The following chart shows the result of the investment strategy applied to Guardion Health Sciences Inc:

Guardion Health Sciences Inc

Note: the dividends potentially given by Guardion Health Sciences Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Guardion Health Sciences Inc

The following chart shows the employed capital evolution since the beginning of the investment strategy on Guardion Health Sciences Inc:

Guardion Health Sciences Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Guardion Health Sciences Inc

In this section, I will compare the three previous investment strategies applied to Guardion Health Sciences Inc.

Equity curve comparison on Guardion Health Sciences Inc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Guardion Health Sciences Inc investment strategy comparison

Employed capital comparison on Guardion Health Sciences Inc

Guardion Health Sciences Inc investment comparison

Performance comparison on Guardion Health Sciences Inc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -23.1% -288.04$ 1246.97$ -8.56%
Momentum 1 quarter -19.71% -592.1$ 3004.72$ -8.01%
Momentum 2 quarters -8.55% -171.35$ 2004.09$ -3.85%
Non-directional 0% 0.0$ 0.0$ 0.0%
Annualized return comparison

Automatic investment

-8.56 %

Momentum 1Q

-3.85 %

Momentum 2Q

-3.85 %

Non-directional

0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Guardion Health Sciences Inc:

Positive correlations

Most correlated stocks this year

  • Guardion Health Sciences Inc

  • Most correlated stocks last 3 months

  • Guardion Health Sciences Inc
  • DADI EDU

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months


    Note: The algorithm computes the probability of correlation between Guardion Health Sciences Inc and the other stocks. There may be false positives or some missing correlated stocks. If the price of Guardion Health Sciences Inc does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name Guardion Health Sciences Inc
    Country United States
    City San Diego
    Address 15150 Avenue of Science
    Phone 858 605 9055
    Website www.guardionhealth.com
    FullTime employees 13
    Industry Drug Manufacturers—Specialty & Generic
    Sector Healthcare
    Exchange XNAS
    Ticker GHSI
    Market www.nasdaq.com

    Guardion Health Sciences Inc ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown